HEV seroprevalence can significantly change after re-assessment
J Med Virol
.
2018 May;90(5):783-785.
doi: 10.1002/jmv.25039.
Epub 2018 Feb 19.
Authors
Maciej Bura
1
,
Michał Michalak
2
,
Małgorzata Łagiedo-Żelazowska
3
,
Alicja Bukowska
4
,
Aleksandra Bura
5
,
Iwona Mozer-Lisewska
1
Affiliations
1
Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznań, Poland.
2
Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznań, Poland.
3
Department of Immunology, Chair of Clinical Immunology, Poznan University of Medical Sciences, Poznań, Poland.
4
Regional Blood Center in Poznan, Poznań, Poland.
5
Department of Infectious Diseases, Joseph Strus Multidisciplinary City Hospital in Poznan, Poznań, Poland.
PMID:
29388686
DOI:
10.1002/jmv.25039
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Genotype
Hepatitis Antibodies
Hepatitis E*
Humans
Immunoglobulin G
Pregnancy
Pregnancy, High-Risk
Prevalence
Seroepidemiologic Studies
Substances
Hepatitis Antibodies
Immunoglobulin G